Treatment adherence in patients with type 2 diabetes mellitus correlates with different coping styles, low perception of self-influence on disease, and depressive symptoms

References

• SabateEAdherence to Long-Term Therapies: Evidence for ActionGenevaWHO2003
   Google Scholar
• CampbellRKRecommendations for improving adherence to type 2 diabetes mellitus therapy–focus on optimizing insulin-based therapyAm J Manag Care2012183 supplS55S6122558943
   PubMedGoogle Scholar
• PeyrotMMcMurryJFJrKrugerDFA biopsychosocial model of glycemic control in diabetes: stress, coping and regimen adherenceJ Health Soc Behav199940214115810467761
   PubMed Web of Science ®Google Scholar
• KokoszkaAKrótka metoda oceny poczucia wpływu na przebieg choroby: opis wersji dla osób z cukrzycą [Brief measure to assess perception of self-influence on the disease course. Version for diabetes]Przegl Lek200562874274516521488
   PubMedGoogle Scholar
• KokoszkaAJodko-ModlińskaAObrębskM[webpage on the Internet]Psychodiabetic kit and its application in clinical practice and researchMasuoKType 2 Diabetes Available from: http://www.intechopen.com/books/type-2-diabetes/psychodiabetic-kit-and-its-application-in-clinical-practice-and-researchAccessed September 18, 2010
   Google Scholar
• Polish Diabetes AssociationClinical recommendations for the management of patients with diabetesClin Diabetol20105suppl AA1A76
   Google Scholar
• ICD10Data.com [webpage on the Internet]ICD-10-CM Diagnosis Code Available from: http://www.icd10data.com/ICD10CM/Codes/E00-E89/E08-E13/E11-/E11Accessed November 12, 2016
   Google Scholar
• KokoszkaARadzioRKotWBrief method of evaluating coping with disease: versions for men and womenDiabet Prakt20089111
   Google Scholar
• BonsignoreMBarkowKJessenFHeunRValidity of the five-item WHO Well-Being Index (WHO-5) in an elderly populationEur Arch Psychiatry Clin Neurosci2001251suppl 2II27II3111824831
   PubMedGoogle Scholar
• HajosTRPouwerFSkovlundSEPsychometric and screening properties of the WHO-5 well-being index in adult outpatients with Type 1 or Type 2 diabetes mellitusDiabet Med2013302e63e6923072401
   PubMed Web of Science ®Google Scholar
• SnoekFJKerschNYEldrupEMonitoring of individual needs in diabetes (MIND): baseline data from the cross-national diabetes attitudes, wishes, and needs (DAWN) MIND studyDiabetes Care201134360160321266654
   PubMed Web of Science ®Google Scholar
• Psychiatric Research Unit, WHO Collaborating Centre in Mental HealthWHO-5 Questionnaires Available from: http://www.psykiatri-regionh.dk/who-5/Documents/WHO5_Polish.pdfAccessed September 20, 2010
   Google Scholar
• BoehmBOVazJABrondstedLHomePDLong-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetesEur J Intern Med200415849650215668084
   PubMedGoogle Scholar
• McNallyPGDeanJDMorrisADWilkinsonPDCompionGHellerSRUsing continuous glucose monitoring to measure the frequency of low glucose values when using biphasic insulin aspart 30 compared with biphasic human insulin 30: a double-blind crossover study in individuals with type 2 diabetesDiabetes Care20073051044104817277042
   PubMed Web of Science ®Google Scholar
• WolnikBLukaszewiczMTreatment intensification with insulin analogs in type 2 diabeticsDiabet Prakt20089209219
   Google Scholar
• GumprechtJBenroubiMBorziVIntensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE observational studyInt J Clin Pract200963696697219504715
   PubMed Web of Science ®Google Scholar
• HermansenKColomboMStorgaardHOstergaardAKolendorfKMadsbadSImproved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetesDiabetes Care200225588388811978685
   PubMed Web of Science ®Google Scholar
• JacobsenLVSogaardBRiisAPharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspartEur J Clin Pharmacol200056539940311009049
   PubMed Web of Science ®Google Scholar
• da VicoLMonamiMBiffiBTargeting educational therapy for type 2 diabetes: identification of predictors of therapeutic successActa Diabetol201350330931722350098
   PubMed Web of Science ®Google Scholar
• WatsonLWilsonBPAlsopJKumarSWeight and glycaemic control in type 2 diabetes: what is the outcome of insulin initiation?Diabetes Obes Metab201113982383121481128
   PubMed Web of Science ®Google Scholar
• Garay-SevillaMEPorrasJSMalacaraJMCoping strategies and adherence to treatment in patients with type 2 diabetes mellitusRev Invest Clin201163215516121714436
   PubMedGoogle Scholar
• KarlsenBIdsoeTHanestadBRMurbergTBruEPerceptions of support, diabetes-related coping and psychological well-being in adults with type 1 and type 2 diabetesPsychol Health Med200495370
   Google Scholar
• WilloughbyDFKeeCCDemiAParkerVCoping and psychosocial adjustment of women with diabetesDiabetes Educ200026110511210776102
   PubMed Web of Science ®Google Scholar
• LazarusRSFolkmanSStress, Appraisal and CopingNew York, NYSpringer1984
   Google Scholar
• MacrodimitrisSDEndlerNSCoping, control, and adjustment in Type 2 diabetesHealth Psychol200120320821611403218
   PubMed Web of Science ®Google Scholar
• ZeidnerMSaklofskeDHAdaptive and maladaptive copingZeidnerMEndlerNSHandbook of Coping: Theory, Research and ApplicationsNew York, NYWiley1996505531
   Google Scholar
• AljasemLIPeyrotMWissowLRubinRRThe impact of barriers and self-efficacy on self-care behaviors in type 2 diabetesDiabetes Educ200127339340411912800
   PubMed Web of Science ®Google Scholar
• BanduraASelf-efficacyRamachaudranVSEncyclopedia of Human Behavior4New York, NYAcademic Press19947181
   Google Scholar
• SarkadiAVegARosenqvistUThe influence of participant’s self-perceived role on metabolic outcomes in a diabetes group education programPatient Educ Couns200558213714516009289
   PubMed Web of Science ®Google Scholar
• RubinRRPeyrotMQuality of life and diabetesDiabetes Metab Res Rev199915320521810441043
   PubMed Web of Science ®Google Scholar
• WatkinsKWConnellCMFitzgeraldJTKlemLHickeyTIngersoll-DaytonBEffect of adults’ self-regulation of diabetes on quality-of-life outcomesDiabetes Care200023101511151511023145
   PubMed Web of Science ®Google Scholar
• CampayoAde JongePRoyJFDepressive disorder and incident diabetes mellitus: the effect of characteristics of depressionAm J Psychiatry2010167558058820123914
   PubMed Web of Science ®Google Scholar
• DucatLPhilipsonLHAndersonBJThe mental health comorbidities of diabetesJAMA2014312769169225010529
   PubMed Web of Science ®Google Scholar
• GonzalezJSPeyrotMMcCarlLADepression and diabetes treatment nonadherence: a meta-analysisDiabetes Care200831122398240319033420
   PubMed Web of Science ®Google Scholar
• LustmanPJAndersonRJFreedlandKEde GrootMCarneyRMClouseREDepression and poor glycemic control: a meta-analytic review of the literatureDiabetes Care200023793494210895843
   PubMed Web of Science ®Google Scholar
• AndersonRJFreedlandKEClouseRELustmanPJThe prevalence of comorbid depression in adults with diabetes: a meta-analysisDiabetes Care20012461069107811375373
   PubMed Web of Science ®Google Scholar
• LiCFordESStrineTWMokdadAHPrevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance systemDiabetes Care200831110510717934145
   PubMed Web of Science ®Google Scholar